本页面由Tiger Trade Technology Pte. Ltd.提供服务

Catalyst Pharmaceutical Partners

24.86
+0.67002.77%
盘后25.000.1400+0.56%17:55 EST
成交量:98.95万
成交额:2,448.94万
市值:30.56亿
市盈率:14.55
高:25.00
开:24.26
低:24.19
收:24.19
52周最高:26.58
52周最低:19.05
股本:1.23亿
流通股本:1.15亿
量比:0.81
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):1.71
每股收益(LYR):1.31
净资产收益率:27.52%
总资产收益率:17.74%
市净率:3.32
市盈率(LYR):18.98

数据加载中...

公司资料

公司名字:
Catalyst Pharmaceutical Partners
交易所:
NASDAQ
成立时间:
2002
员工人数:
181
公司地址:
355 Alhambra Circle,Suite 801,Coral Gables,Florida,United States
邮编:
33134
电话:
传真:
- -
简介:
Catalyst Pharmaceuticals, Inc.于2006年7月在特拉华州注册成立。该公司是一家商业阶段、以患者为中心的生物制药公司,专注于为患有罕见和难以治疗的疾病的患者提供新的高质量药物的许可、开发和商业化。该公司利用协调一致的勤奋努力,寻找能够改善那些患有罕见或难以治疗的疾病的人的生活的疗法。

董事

名称
职位
Patrick J. McEnany
Non-Executive Chairman of the Board
Richard J. Daly
Director, President and Chief Executive Officer
David S. Tierney
Independent Director
Donald A. Denkhaus
Independent Director
Molly Harper
Lead Independent Director
Tamar Thompson
Independent Director
Daniel J. Curran
Director

股东

名称
职位
Richard J. Daly
Director, President and Chief Executive Officer
Steven R. Miller
Executive Vice President, Chief Operating Officer and Chief Scientific Officer
Michael W. Kalb
Executive Vice President,Treasurer, Chief Financial Officer and Principal Accounting Officer
Brian Elsbernd
Chief Compliance Officer and Chief Legal Officer
Gary Ingenito
Chief Medical Officer and Chief Regulatory Officer
Gregg Russo
Chief Human Resources Officer
Jeffrey Del Carmen
Executive Vice President and Chief Commercial Officer
Preethi Sundaram
Chief Strategy Officer